Bimatoprost/timolol - Laboratoires Thea
Alternative Names: T-4030; Timolol/bimatoprost - Laboratoires TheaLatest Information Update: 24 Oct 2023
At a glance
- Originator Laboratoires Thea
- Class Amides; Antiglaucomas; Antihypertensives; Lipids; Morpholines; Propanolamines; Synthetic prostaglandins; Thiadiazoles
- Mechanism of Action Beta-adrenergic receptor antagonists; Prostaglandin F2alpha receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Glaucoma; Ocular hypertension
Most Recent Events
- 30 May 2023 Laboratoires Thea completes a phase-III clinical trial in Glaucoma in Bulgaria (Ophthalmic) (NCT04898387)
- 30 May 2023 Laboratoires Thea completes a phase-III clinical trial in Ocular hypertension in Bulgaria (Ophthalmic) (NCT04898387)
- 26 Jul 2021 Chemical structure information added